Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

Becomes the first drug approved to treat Sézary syndrome

- PMLiVE

Healthcare Comms news

Bmore creative renames, Kyne partners up with Agora and Oxford PharmaGenesis expands to Australia

- PMLiVE

ABPI hits out at ‘punitive’ UK medicines cost controls

Steep rise in charges an 'alarming signal' amid Brexit uncertainty

- PMLiVE

Pharma survey: No Brexit is the best option

But many believe a 'no deal' Brexit most likely outcome

- PMLiVE

Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

Firm relying on launch success in pressured US market

omnichannel

Omni-empathy

So, we’ve arrived. Our work has stepped beyond multichannel to omnichannel. We can be and in fact are everywhere, all the time. We are omni-present. We are God. Or are...

Page & Page Health

- PMLiVE

Spark sputters on haemophilia A gene therapy safety scare

Investors compare data unfavourably with BioMarin rival

- PMLiVE

Brand teams: why are some smarter than others?

It’s not for the reasons you think

Dovetail pilots new approach to joint working

Award-winning healthcare collaboration specialists Dovetail will this month pilot a new programme of workshops on improving joint working between industry and clinicians for the benefit of patients. The first meeting...

Dovetail

Rare diseases and orphan drugs: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs, which includes links to...

Inizio

Conducting research for publication video

APAC Director Pei Li Teh explains how real world insights provide an opportunity for brands to find, demonstrate and communicate their real value to patients, healthcare and society.Watch the video: https://bit.ly/2OcOWNu

Inizio

Conference research case study

How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links